Publications by authors named "Mu Yan Cai"

Claim this Profile
S
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Run-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, Bai-Wei Zhao, Wei Wang, Mu-Yan Cai

Cell Rep Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMRNet: Ensemble deep learning models for predicting mismatch repair deficiency in endometrial cancer from histopathological images.
Li-Li Liu, Bing-Zhong Jing, Xuan Liu, Rong-Gang Li, Zhao Wan, Mu-Yan Cai

Cell Rep Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAOK1 promotes filament formation in HR repair through phosphorylating USP7.
Tian-Chen Zhu, Zhang-Ping He, Shu-Ting Li, Lin Zheng, Xue-Yi Zheng, Xiao-Xia Cai, Mu-Yan Cai

Proc Natl Acad Sci U S A· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial.
Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, Yong-Ming Chen, Yuan-Fang Li, Cheng-Cai Liang, Mu-Yan Cai

Signal Transduct Target Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional landscape and predictive potential of long noncoding RNAs in peritoneal recurrence of gastric cancer.
Xiao-Xia Cai, Guo-Ming Chen, Zi-Qi Zheng, Yi-Xin Yin, Shuang Wang, Cheng-Cai Liang, Mu-Yan Cai

Mol Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma.
Ying-Wen Wu, Li-Jun Wei, Xia Yang, Hao-Yu Liang, Mu-Yan Cai

Oncologist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma.
Yang Liu, Shuang-Yan Ye, Shuai He, Dong-Mei Chi, Xiu-Zhi Wang, Mu-Yan Cai

Nat Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning.
Guang-Yu Ding, Wei-Min Tan, You-Pei Lin, Yu Ling, Wen Huang, Mu-Yan Cai

BMC Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma.
Kang-Bo Huang, Cheng-Peng Gui, Yun-Ze Xu, Xue-Song Li, Hong-Wei Zhao, Cai-Xia Li, Mu-Yan Cai

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma.
Shi-Hui Hao, Xiao-Dan Ma, Li Xu, Jing-Dun Xie, Zi-Hao Feng, Mu-Yan Cai

Drug Resist Updat· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Mu-Yan Cai

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Shu-Qiang Yuan, Run-Cong Nie, Ying Jin, Cheng-Cai Liang, Yuan-Fang Li, Mu-Yan Cai

Nat Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, Qi Wu, Mu-Yan Cai

Cancer Commun (Lond)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.
Jie Zhou, Run-Cong Nie, Zhang-Ping He, Xiao-Xia Cai, Jie-Wei Chen, Mu-Yan Cai

Adv Sci (Weinh)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
Cheng-Peng Gui, Yu-Hang Chen, Hong-Wei Zhao, Jia-Zheng Cao, Tian-Jie Liu, Cai-Xia Li, Mu-Yan Cai

Lancet Digit Health· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma.
Yi-Hong Ling, Meng-Ni Liu, Yi-Xin Yin, Zhong-Guo Zhou, Jie-Wei Chen, Mu-Yan Cai

Signal Transduct Target Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
Yi-Xin Yin, Yi-Hong Ling, Xiao-Li Wei, Cai-Yun He, Bing-Zhi Wang, Mu-Yan Cai

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors.
You-Cheng Zhang, Tian-Chen Zhu, Run-Cong Nie, Liang-He Lu, Zhi-Cheng Xiang, Mu-Yan Cai

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity.
Jie Zhou, Run-Cong Nie, Yi-Xin Yin, Xiao-Xia Cai, Dan Xie, Mu-Yan Cai

Dis Markers· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: A cohort study with external extension analysis.
Jin-Ling Duan, Min-Hua Deng, Zhi-Cheng Xiang, Jin-Long Hu, Chun-Hua Qu, Mu-Yan Cai

Front Cell Dev Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma" [Canc. Lett. 414 (2018) 71-80].
Li-Li Wang, Xiao-Han Jin, Mu-Yan Cai, Hai-Gang Li, Jie-Wei Chen

Cancer Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning.
Wu Jiang, Wei-Jian Mei, Shuo-Yu Xu, Yi-Hong Ling, Wei-Rong Li, Mu-Yan Cai

EBioMedicine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Analysis Uncovers the Prognostic and Immunogenetic Feature of Pyroptosis in Gastric Carcinoma: Indication for Immunotherapy.
Jie Zhou, Run-Cong Nie, Yi-Xin Yin, Yun Wang, Shu-Qiang Yuan, Mu-Yan Cai

Front Cell Dev Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients.
Yiyang Zhang, Lianghe Lu, Zhangping He, Zhishen Xu, Zhicheng Xiang, Xiaoxia Cai, Mu-Yan Cai

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma.
Jin-Ling Duan, Wei Chen, Juan-Juan Xie, Mao-Lei Zhang, Run-Cong Nie, Mu-Yan Cai

Mol Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis